Catalyst Wire Dossier Catalyst Wire Dossier

Aliskiren/Enalapril

aliskiren/enalapril · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aliskiren/Enalapril, covering 2016-11-25 to 2016-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure [Phase 3]

See pricing